Staphylococcus aureus infection
MONDO:0005545An infectious process in which the bacteria Staphylococcus aureus is present.
66 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Fish oil and eyelid wipes: a new hope for Kids' stubborn styes?
Disease control Not yet recruitingThis study tests whether omega-3 supplements or a special anti-demodex eyelid cleanser can help treat and prevent chalazia (styes) in children aged 4 to 17. All 168 participants will use warm compresses, and they will be split into three groups: one adds omega-3 fish oil and stan…
Phase: PHASE2 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New light treatment could zap stubborn eyelid lumps
Disease control Not yet recruitingThis study tests if intense pulsed light (IPL) is a safe and effective way to treat chalazion, a common eyelid lump. About 40 adults with an inflamed chalazion will receive IPL or a control treatment. The main goal is to see if the lump shrinks by at least 80% four weeks after th…
Phase: NA • Sponsor: Lumenis Be Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could a heart drug beat a deadly blood infection? new trial aims to find out
Disease control Not yet recruitingThis study tests whether adding clopidogrel, a drug usually used to prevent blood clots, to standard antibiotics improves outcomes for adults with a serious Staphylococcus aureus bloodstream infection. About 230 hospitalized patients will be randomly assigned to receive clopidogr…
Phase: PHASE2 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Double trouble for staph: could two antibiotics beat one?
Disease control Not yet recruitingThis study looks at whether using a combination of antibiotics is more effective than a single antibiotic for treating serious staph infections in the blood. About 2,096 adults with either methicillin-sensitive or methicillin-resistant staph will be randomly assigned to one group…
Phase: PHASE4 • Sponsor: Intermountain Health Care, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Virus cocktail takes on superbugs in cystic fibrosis trial
Disease control Not yet recruitingThis early-stage study tests whether adding specially-made viruses (phages) to standard antibiotics can safely treat stubborn lung infections in adults with cystic fibrosis. About 30 participants will receive a 7-day course of both treatments. The main goal is to check safety, bu…
Phase: PHASE1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Nose ointment may ease Radiation's brutal mouth pain
Symptom relief Not yet recruitingThis study tests whether a common antibiotic ointment applied inside the nose can reduce severe mouth and throat pain caused by radiation therapy in head and neck cancer patients. About 126 participants will receive either the antibiotic or a placebo, and neither they nor their d…
Phase: PHASE2 • Sponsor: David Palma • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Does the setting of care affect whether kids finish their antibiotics?
Knowledge-focused Not yet recruitingThis observational study looks at whether children aged 3 months to 16 years are more likely to complete their full course of antibiotics when prescribed at a primary care clinic versus a hospital emergency department. Researchers surveyed parents by phone after treatment ended t…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Immune cell clues may unlock better HS treatment
Knowledge-focused Not yet recruitingThis study looks at how certain immune cells, called MAIT cells, behave in people with hidradenitis suppurativa (HS), a painful skin condition. Researchers will take skin and blood samples from 45 adults with HS and compare them to samples from people with other skin diseases. Th…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC